1. Chemical identity reference
Public chemical databases list Nicotinamide Riboside Tartrate under the stated identity; this reference supports identity review and does not replace the batch COA.
Citation: PubChem compound recordView source
NR Tartrate
CAS 2415657-86-0
Purity≥98.0% (HPLC)
Solid NR tartrate powder for NAD+ precursor formulations and NR salt-form selection
Nicotinamide riboside tartrate (NR Tartrate, CAS 2415657-86-0) is supplied by PathGene as a solid powder with ≥98.0% HPLC purity. Tartrate, chloride and hydrogen malate are different NR salt forms, each with its own specification. Batch COA and evaluation samples are available. MOQ: 1 kg. NAD+ ingredients
Quote / sample & delivery
Key Specifications
| Product Positioning | Solid NR tartrate powder for NAD+ precursor formulations and NR salt-form selection |
| Application Scenarios | NAD+ precursor formulation · nucleotide metabolism research · water-soluble powder development |
| CAS Number | 2415657-86-0 |
| Purity | ≥98.0% (HPLC) |
| Molecular Formula | C15H20N2O11 |
| Molecular Weight | 404.33 g/mol |
| Appearance | Almost white to off-white solid powder |
| Solubility | Soluble in water |
| Storage | Seal, keep dry and protected from light; below 4°C for long-term storage |
| Shelf Life | 2028-06-24 |
Procurement & delivery
Supply details confirmed by intended use, volume and target market
Nicotinamide riboside tartrate is a tartrate salt of nicotinamide riboside. The salt form is qualified by its identity, assay, moisture and storage profile rather than by the free-base identity alone. These are distinct salt forms. Specify the tartrate identity and assay basis, and compare counter-ion composition, moisture and formulation requirements rather than assuming equal weights provide an equivalent material. Product image: AI-generated ingredient illustration; actual batch appearance is subject to the sample and COA. PathGene NR tartrate powder is supplied from a chemical-synthesis process, followed by tartrate salt formation and powder isolation.
NR Tartrate Bulk Supply
PathGene supplies NR Tartrate, CAS 2415657-86-0, with specification ≥98.0% (HPLC).
Ingredient Identity
Nicotinamide riboside in tartrate-salt solid powder form; NR chloride and hydrogen malate are listed separately.
Batch Quality Documentation
Batch COA supports the quality evaluation of NR Tartrate and the agreed purchasing specification.
Evaluation Samples
Request NR Tartrate samples for incoming-quality evaluation and project trials.
Supply and Packaging
MOQ: 1 kg. Packaging options: 1 g, 100 g, 1 kg, 25 kg.
Test items, specifications and results for the listed batch are shown here. View or request a COA in the quality documents section.
Batch No.
PGNRT-260625
Test date
2026-06-25
Specification
Q/PGNRT-INHOUSE
Pack size
25 kg/drum
Storage
Seal, keep dry and protected from light; below 4°C for long-term storage
Conclusion
Conforms
| Test Item | Specification | Result |
|---|---|---|
| Appearance | Almost white or off-white solid | Almost white |
| Assay (HPLC, dry basis) | 98–102% | 99.5% |
| Purity (HPLC) | ≥98.0% | 99.56% |
| Water (KF) | ≤2% | 0.26% |
| Total microbial count | <1000 CFU/g | Conforms |
View an available COA in the quality documents section. Check the document for its product form and batch; request a signed COA for your purchasing or shipment batch separately.

Hard capsules

Powders

Softgels

Tablets

Sublingual tablets

Oral dissolving films
Chemically synthesized NR tartrate is a solid powder, CAS 2415657-86-0; establish salt identity and assay basis separately from chloride and NRHM.
99.5%
Assay (HPLC, dry basis)
99.56%
Purity (HPLC)
0.26%
Water (KF)
PGNRT-260625 · Results apply to this lot; interpret purity, assay and water on their respective bases.
Composition candidates, processing sequences and tests support pilot design. Confirm candidate excipients and processes using this material in the actual finished formulation.
Study combinations, individual-ingredient mechanisms and product precedents are distinguished; expand each entry for scope and pilot-development checks.
A documented NR/pterostilbene combination offers a concrete benchmark for capsule and powder formulation work. Compare the declared NR active-moiety amount across salt forms, then screen blend uniformity, moisture uptake, oxidation, dissolution and shelf stability before selecting excipients or a delivery format.
Expand research and formulation notes +Collapse research and formulation notes −Development rationale: A documented NR/pterostilbene combination offers a concrete benchmark for capsule and powder formulation work. Compare the declared NR active-moiety amount across salt forms, then screen blend uniformity, moisture uptake, oxidation, dissolution and shelf stability before selecting excipients or a delivery format.
Evidence scope: A randomized human trial studied a specific NR/pterostilbene product in adults aged 60–80; it does not establish equivalence for NR tartrate, this raw-material grade, a different ratio, or a new finished formula. Treat it as formulation precedent, not proof of synergy or a health claim.
Pilot checks: Retain individual-ingredient, blend and carrier controls; check uniformity and post-process assays before packaged samples, documenting study formulations separately from new candidates.
2017 · Repeat dose NRPT (nicotinamide riboside and pterostilbene) increases NAD+ levels in humans safely and sustainably: a randomized, double-blind, placebo-controlled study. ↗Literature-Supported Research Directions
Public chemical databases list Nicotinamide Riboside Tartrate under the stated identity; this reference supports identity review and does not replace the batch COA.
Citation: PubChem compound recordView source
A 2021 materials study prepared and characterized nicotinamide riboside hydrogen-tartrate salts, including crystal structures, aqueous solubility and stability under different pH and temperature conditions. This supports salt-form and process research; it does not establish human bioavailability or clinical outcomes for this specific commercial material. Stereochemistry and salt stoichiometry should be checked against the supplied specification.
Citation: Schabert et al. Molecules. 2021;26:2729.View source
Randomized human studies have examined nicotinamide riboside chloride and reported changes in blood NAD-related metabolites. Those results provide context for NR-pathway research, but chloride-form studies do not establish equivalent exposure or performance for NR tartrate.
Citation: Conze et al. Safety and Metabolism of Long-term Administration of Nicotinamide Riboside Chloride. Sci Rep. 2019.View source
Note: For ingredient R&D and scientific information; findings depend on model, dose, formulation and population and do not constitute a treatment claim or efficacy guarantee.
Lead Time
3–5business days
Standard products are generally in stock; confirm the exact lead time with us.
Minimum Order
1 kg
Samples, pilot trials, and commercial volumes are supported.

Foil Pouch
Sealed, moisture-protective inner packaging

Fiber Drum
Standard outer packaging for bulk transport

Bulk Shipping
Palletized and stretch-wrapped for protection
Ambient storage: foil pouch + fiber drum; temperature controlled: foil pouch + insulated box/carton. Confirm by product.
Custom packaging: Custom foil bags or HDPE drums, GMP label printing, and export documentation are available. Contact us for a quote.Images are packaging illustrations.
Certifications
The stated purity and batch result are shown separately. Confirm the method, dry-basis calculation and salt or hydrate form against the current COA.
Formulation work should confirm concentration, pH, light, moisture and hold-time controls for Nicotinamide Riboside Tartrate; suitability depends on the final format and market requirements.
The raw-material MOQ for NR tartrate powder is 1 kg, with pack options of 1 g, 100 g, 1 kg, 25 kg.
These are distinct salt forms. Specify the tartrate identity and assay basis, and compare counter-ion composition, moisture and formulation requirements rather than assuming equal weights provide an equivalent material.
Nicotinamide riboside tartrate, CAS 2415657-86-0, is supplied as a solid powder with an HPLC purity specification of ≥98.0%. It is the tartrate salt form of NR. The matching batch COA supports review of salt identity, purity and agreed quality items.
The powder mass of each NR salt includes a different counter-ion composition. Before comparing cost per NR component, verify salt identity, composition, water and assay basis, then calculate using the batch results. A kilogram price for one salt does not automatically represent the same NR quantity as another.
Documents are subject to product and batch availability; third-party reports are provided only when applicable.
Quality documents
The specification sheet defines acceptance limits. The COA shows actual batch results, which may vary by batch. Third-party reports are provided only for products or batches that have been independently tested.
Stable acceptance criteria · Available on request
Actual test data · Check the COA for the applicable batch
Technical Resources
Compare the three NR salt powders by exact identity, CAS, assay basis and batch evidence, with direct links to PathGene chloride, hydrogen malate and tartrate specifications.
NMN, NAD+, NR, NRHM, NMNH, and NADH are often marketed as interchangeable "NAD+ precursors," but they differ in CAS identity, purity, salt form, and cost. This is a side-by-side decision guide for picking the right form for your formulation.
Related Products

NMN Powder (β-Nicotinamide Mononucleotide)

β-Nicotinamide Adenine Dinucleotide Powder

Nicotinamide Riboside Chloride Powder

Nicotinamide Riboside Hydrogen Malate Powder
Interested in NR Tartrate?
Our R&D team will respond to your inquiry or sample request within 24 hours.
Scan to add WeChat

Alex Huang · Mon–Fri 9am–6pm CST